← All organizations

Neurotech USA

For profitWebsite ↗

Also known as: Neurotech International | Neurotech International Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 1, 2026

Timeline

1990s

Jun 1, 1995
Neurotech USA— Founded

Drugs by trial phase (2 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

cannabis

Phase 1 (1 own, 0 via acquisition)

revakinagene taroretcel

Indications

Studied for

Telangiectasis

Recent trials (8)

NCT07257939CollaboratorPhase 3Jul 1, 2026
NCT07257978CollaboratorPhase 2/Phase 3Jul 1, 2026
NCT06713447CollaboratorPhase 1Dec 1, 2024
NCT06621043CollaboratorPhase 1/Phase 2Sep 20, 2023
NCT06621888CollaboratorPhase 1/Phase 2Jun 2, 2023
NCT05626959CollaboratorPhase 2/Phase 3Nov 30, 2022
NCT05516407CollaboratorPhase 1/Phase 2Apr 1, 2021
NCT01327911Study chairPhase 1May 1, 2011

Details

Founded: Lincoln, RI, US Jun 1, 1995
Last known activity: Jul 1, 2026